Danaher Corporation $DHR Shares Purchased by S Bank Fund Management Ltd

S Bank Fund Management Ltd boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 44.8% in the third quarter, HoldingsChannel.com reports. The fund owned 41,750 shares of the conglomerate’s stock after buying an additional 12,912 shares during the quarter. Danaher comprises about 1.1% of S Bank Fund Management Ltd’s investment portfolio, making the stock its 20th biggest holding. S Bank Fund Management Ltd’s holdings in Danaher were worth $8,277,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of DHR. WFA of San Diego LLC acquired a new position in shares of Danaher during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new position in Danaher in the 2nd quarter valued at about $27,000. TruNorth Capital Management LLC acquired a new stake in shares of Danaher during the third quarter worth $28,000. Red Tortoise LLC boosted its stake in Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Finally, Tripletail Wealth Management LLC purchased a new stake in Danaher in the 3rd quarter valued at about $31,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 5,174 shares of the stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the transaction, the senior vice president owned 2,625 shares of the company’s stock, valued at approximately $552,352.50. This represents a 66.34% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Brian W. Ellis sold 21,776 shares of Danaher stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $219.23, for a total value of $4,773,952.48. Following the sale, the senior vice president owned 14,553 shares in the company, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 30,248 shares of company stock worth $6,609,663. 11.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on DHR. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. TD Cowen boosted their price objective on shares of Danaher from $260.00 to $270.00 and gave the company a “buy” rating in a research note on Wednesday, January 7th. KeyCorp reiterated an “overweight” rating on shares of Danaher in a report on Thursday, December 18th. Cowen restated a “buy” rating on shares of Danaher in a research note on Wednesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on Danaher from $235.00 to $250.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Twenty-one investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $249.92.

Danaher Stock Performance

Shares of NYSE:DHR opened at $239.22 on Tuesday. The company has a market cap of $168.97 billion, a P/E ratio of 49.32, a PEG ratio of 4.24 and a beta of 0.89. Danaher Corporation has a one year low of $171.00 and a one year high of $258.23. The business’s 50-day simple moving average is $226.27 and its 200 day simple moving average is $210.94. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.10 and a current ratio of 1.52.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The company had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. During the same quarter last year, the firm posted $1.71 earnings per share. The business’s quarterly revenue was up 4.4% on a year-over-year basis. On average, sell-side analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Friday, December 26th. Danaher’s payout ratio is presently 26.39%.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.